Company intelligence / Profile preview
Trion Research
Planegg, Bavaria, Germanytrionresearch.com ↗
- Ownership
- Private
- Employees
- ~10
- Development stage
- Other
01
Overview
Trion Research is an independent research organization with a focus on developing and supporting trifunctional bispecific antibodies (Triomab®), including contributions to the development and approval of catumaxomab (Removab®). Several pipeline compounds have reached clinical development, but active internal programs appear to be in preclinical or discovery stages, with clinical validation (catumaxomab) having occurred via partnerships and out-licensing.
- Therapeutic areas
- OncologyImmunology
- Modalities
- Bispecific monoclonal antibodyMonoclonal antibodyAntibody-drug conjugateProtein
- Industry
- Biotech
02
Drug pipeline
1 asset03
Partnerships
Lindis BiotechTrion Pharma GmbH
Beyond the preview
Go deeper on Trion Research.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Trion Research.